Report Detail
Global Aliskiren Market Growth (Status and Outlook) 2019-2024
- RnM3134504 |
- 18 March, 2019 |
- Global |
- 116 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.
According to this study, over the next five years the Aliskiren market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Aliskiren business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Aliskiren market by product type, application, key companies and key regions.
This study considers the Aliskiren value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
150 mg Tablet
300 mg Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Noden Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Aliskiren market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Aliskiren market by identifying its various subsegments.
Focuses on the key global Aliskiren players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Aliskiren with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Aliskiren submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Aliskiren Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Aliskiren Market Size 2014-2024
- 2.1.2 Aliskiren Market Size CAGR by Region
- 2.2 Aliskiren Segment by Type
- 2.2.1 150 mg Tablet
- 2.2.2 300 mg Tablet
- 2.3 Aliskiren Market Size by Type
- 2.3.1 Global Aliskiren Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Aliskiren Market Size Growth Rate by Type (2014-2019)
- 2.4 Aliskiren Segment by Application
- 2.4.1 Hospital
- 2.4.2 Drug store
- 2.5 Aliskiren Market Size by Application
- 2.5.1 Global Aliskiren Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Aliskiren Market Size Growth Rate by Application (2014-2019)
3 Global Aliskiren by Players
- 3.1 Global Aliskiren Market Size Market Share by Players
- 3.1.1 Global Aliskiren Market Size by Players (2017-2019)
- 3.1.2 Global Aliskiren Market Size Market Share by Players (2017-2019)
- 3.2 Global Aliskiren Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Aliskiren by Regions
- 4.1 Aliskiren Market Size by Regions
- 4.2 Americas Aliskiren Market Size Growth
- 4.3 APAC Aliskiren Market Size Growth
- 4.4 Europe Aliskiren Market Size Growth
- 4.5 Middle East & Africa Aliskiren Market Size Growth
5 Americas
- 5.1 Americas Aliskiren Market Size by Countries
- 5.2 Americas Aliskiren Market Size by Type
- 5.3 Americas Aliskiren Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Aliskiren Market Size by Countries
- 6.2 APAC Aliskiren Market Size by Type
- 6.3 APAC Aliskiren Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Aliskiren by Countries
- 7.2 Europe Aliskiren Market Size by Type
- 7.3 Europe Aliskiren Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Aliskiren by Countries
- 8.2 Middle East & Africa Aliskiren Market Size by Type
- 8.3 Middle East & Africa Aliskiren Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Aliskiren Market Forecast
- 10.1 Global Aliskiren Market Size Forecast (2019-2024)
- 10.2 Global Aliskiren Forecast by Regions
- 10.2.1 Global Aliskiren Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Aliskiren Forecast by Type
- 10.8 Global Aliskiren Forecast by Application
11 Key Players Analysis
- 11.1 Noden Pharma
- 11.1.1 Company Details
- 11.1.2 Aliskiren Product Offered
- 11.1.3 Noden Pharma Aliskiren Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Noden Pharma News
...
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Aliskiren . Industry analysis & Market Report on Aliskiren is a syndicated market report, published as Global Aliskiren Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Aliskiren market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
